UBE2D2 Human

Ubiquitin Conjugating Enzyme E2D2 Human Recombinant
Cat. No.
BT17590
Source
E.coli.
Synonyms

Ubiquitin-conjugating enzyme E2D 2 (homologous to yeast UBC4/5), UBC4, Ubiquitin carrier protein D2, Ubiquitin-conjugating enzyme E2-17 kDa 2, Ubiquitin-protein ligase D2, UBCH5B, EC 6.3.2.19, E2(17)KB2, PUBC1, UBC4/5, UBC5B, UBCH4.

Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

UBE2D2 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 147 amino acids (1-147) and having a molecular mass of 16.7kDa. The UBE2D2 is purified by proprietary chromatographic techniques. 

Product Specs

Introduction
UBE2D2, a member of the E2 ubiquitin-conjugating enzyme family, plays a crucial role in ubiquitination processes. It is involved in the ubiquitination of the tumor-suppressor protein p53, a process induced by an E3 ubiquitin-protein ligase. Additionally, UBE2D2 catalyzes the ubiquitination of IkB-alpha in a manner dependent on SCFB-TRCP and phosphorylation.
Description
Recombinant UBE2D2, derived from humans and produced in E.coli, is a single, non-glycosylated polypeptide chain. It comprises 147 amino acids (1-147) and exhibits a molecular mass of 16.7kDa. The purification process of UBE2D2 involves proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized through filtration.
Formulation
The UBE2D2 solution is provided at a concentration of 0.5mg/ml and contains the following components: 20mM MES (pH 6.0), 50mM NaCl, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the UBE2D2 solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing of the solution should be avoided.
Purity
The purity of UBE2D2 is greater than 95%, as determined by SDS-PAGE analysis.
Synonyms

Ubiquitin-conjugating enzyme E2D 2 (homologous to yeast UBC4/5), UBC4, Ubiquitin carrier protein D2, Ubiquitin-conjugating enzyme E2-17 kDa 2, Ubiquitin-protein ligase D2, UBCH5B, EC 6.3.2.19, E2(17)KB2, PUBC1, UBC4/5, UBC5B, UBCH4.

Source
E.coli.
Amino Acid Sequence

MALKRIHKEL NDLARDPPAQ CSAGPVGDDM FHWQATIMGP NDSPYQGGVF FLTIHFPTDY PFKPPKVAFT TRIYHPNINS NGSICLDILR SQWSPALTIS KVLLSICSLL CDPNPDDPLV PEIARIYKTD REKYNRIARE WTQKYAM. 

Product Science Overview

Introduction

Ubiquitin Conjugating Enzyme E2D2, also known as UBE2D2, is a member of the E2 ubiquitin-conjugating enzyme family. This enzyme plays a crucial role in the ubiquitination process, which is essential for the regulation of protein turnover and various cellular processes in eukaryotic cells .

Ubiquitination Process

Ubiquitination is a post-translational modification where ubiquitin, a small regulatory protein, is attached to a substrate protein. This process involves three main steps:

  1. Activation: Ubiquitin is activated by an E1 ubiquitin-activating enzyme.
  2. Conjugation: The activated ubiquitin is transferred to an E2 ubiquitin-conjugating enzyme, such as UBE2D2.
  3. Ligation: The E3 ubiquitin ligase facilitates the transfer of ubiquitin from the E2 enzyme to the target protein .
Role of UBE2D2

UBE2D2 is responsible for the conjugation step in the ubiquitination process. It acts as an intermediary that transfers ubiquitin from the E1 enzyme to the E3 ligase, which then attaches ubiquitin to the substrate protein. This enzyme is involved in the ubiquitination of several key proteins, including the tumor-suppressor protein p53 and IkB-alpha .

Biological Significance

The ubiquitination process, mediated by UBE2D2, is critical for maintaining cellular homeostasis. It regulates protein degradation, cell cycle progression, DNA repair, and signal transduction. Dysregulation of ubiquitination can lead to various diseases, including cancer, neurodegenerative disorders, and immune system dysfunctions .

Research and Applications

UBE2D2 has been extensively studied for its role in targeted protein degradation. Researchers have developed chimeric E2 enzymes to enhance the degradation of specific proteins, providing a potential therapeutic approach for diseases caused by protein dysregulation . Additionally, UBE2D2 is used in various in vitro assays to study the ubiquitination process and its implications in different biological pathways .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.